Prostate Cancer Press Releases by globenewswire

News Search | All News Topics > Prostate Cancer News Topics: By Country | By State ; Press Releases by Industry Channel
Submit Your Press Release
Distribution channels: Healthcare & Pharmaceuticals Industry
Mar 10, 2025
First Patient Enrolled in Merit Medical’s PREEMIE Study
Mar 10, 2025
BioCardia Announces Japanese Patent for Helix™ Biotherapeutic Delivery System
Mar 10, 2025
Emergent BioSolutions Announces Sale of Baltimore-Bayview Manufacturing Site to Syngene International
Mar 10, 2025
Fusion Biopsy Market to Hit US$0.91 Billion by 2029 with 7.1% CAGR | MarketsandMarkets™.
Mar 10, 2025
HeartSciences Inc. Engages Integrous Communications to Enhance Investor Communications
Mar 10, 2025
Longevity Life Advisors Launches CancerEDGE: A Program Offering Advanced Cancer Genomics and Precision Health Services
Mar 10, 2025
31 Million Patient Journeys, One Mission
Mar 10, 2025
ReShape Lifesciences® Receives Notice of Allowance for U.S. Patent Related to Its Proprietary Diabetes Neuromodulation ...
Mar 10, 2025
Biodexa Announces Successful Outcome of a Type C Meeting with FDA Regarding the Phase 3 Program for eRapa in FAP
Mar 10, 2025
IRADIMED CORPORATION To Participate at the 37th Annual Roth Conference
Mar 10, 2025
New Findings Show how LIXTE’s Lead Clinical Compound, LB-100, is Metabolized to its Active Form
Mar 10, 2025
Inozyme Pharma Reports Full Year 2024 Financial Results and Announces Strategic Prioritization of ENPP1 Deficiency ...
Mar 10, 2025
OKYO Pharma Files for Fast Track Designation with FDA for Urcosimod to Treat Neuropathic Corneal Pain
Mar 10, 2025
Stereotaxis to Present at 37th Annual Roth Conference
Mar 10, 2025
Eradivir announces Phase 2 human challenge study of EV25 in healthy adults infected with influenza
Mar 10, 2025
Northstrive Biosciences Inc. Schedules Pre-IND Meeting with FDA for EL-22, an Obesity Therapy Targeting Fat Loss and ...
Mar 10, 2025
Talkspace Supports U.S. Navy Pilot to Provide Free Virtual Mental Health Services
Mar 10, 2025
Cronos Group Inc. to Speak at the 37th Annual Roth Conference
Mar 10, 2025
BetterLife Announces Debt Conversions
Mar 10, 2025
4DMT Announces First Patients Enrolled in 4FRONT-1 Phase 3 Clinical Trial Evaluating 4D-150 in Wet AMD
Mar 10, 2025
Calidi Biotherapeutics Announces Demonstrated Ability To Deliver Transient Gene Therapy (Payload) To Tumors Using ...
Mar 10, 2025
Aligos Therapeutics Reports Recent Business Progress and Fourth Quarter and Full Year 2024 Financial Results
Mar 10, 2025
Tonix Pharmaceuticals Announces Grant by Medical CBRN Defense Consortium (MCDC) for Development of TNX-801, the Company’...
Mar 10, 2025
Polyrizon Initiates Preclinical Studies for Intranasal Naloxone Targeting Opioid Overdose Based on Its Innovative T&T ...
Mar 10, 2025
SciSparc-Clearmind Collaboration Leads to Publication of Patent Application for Cocaine Addiction Psychedelic ...
Mar 10, 2025
Cognition Therapeutics to Present at Life Sciences Virtual Investor Conference
Mar 10, 2025
Veri Medtech (VRHI) Network Grows To 400 Physicians
Mar 10, 2025
Prelude Therapeutics Reports Full Year 2024 Financial Results and Provides Program Outlook for 2025
Mar 10, 2025
Plus Therapeutics Regains Compliance with Nasdaq Minimum Stockholders’ Equity Requirement
Mar 10, 2025
Clearmind Medicine Announces Publication of Patent for Cocaine Addiction Psychedelic Combination Treatment in South ...
Mar 10, 2025
Aurora Spine Corporation Announces Completion of Enrollment in Groundbreaking REFINE Study: First Prospective, Multi-...
Mar 10, 2025
Exposure Consulting's Leading Environmental Scientist Dr. Alex LeBeau Offers Exclusive Media Interviews on the Growing ...
Mar 10, 2025
The Bluffs Addiction Campuses Unveils Special Forces Veteran Kyle Morgan’s Journey of Recovery
Mar 10, 2025
Avacta Therapeutics to Present at the 2025 Leerink Global Healthcare Conference
Mar 10, 2025
Lungpacer Medical Announces Investigational Device Exemption (IDE) for STARI, Phase 2 Feasibility Clinical Trial
Mar 10, 2025
Mineralys Therapeutics Announces Positive Topline Results from Launch-HTN and Advance-HTN Pivotal Trials of Lorundrostat ...
Mar 10, 2025
MannKind Showcases Efficacy, Safety, and Mealtime Control Data from Recent Pediatric and Adult Studies of Afrezza® at ...
Mar 10, 2025
Fennec Pharmaceuticals Reports Fourth Quarter and Full-Year 2024 Financial Results and Provides Business Update
Mar 10, 2025
5e édition de Brise l’illusion avec Maxime Crépeau et Samuel Piette
Mar 10, 2025
VIVUS Launches QSYMIA® in the United Arab Emirates
Powered by EIN News